Using Multicriteria Decision Analysis to Support Research Priority Setting in Biomedical Translational Research Projects
暂无分享,去创建一个
[1] R. Baltussen,et al. Priority setting of health interventions: the need for multi-criteria decision analysis , 2006, Cost effectiveness and resource allocation : C/E.
[2] Theodor J. Stewart,et al. Multiple criteria decision analysis - an integrated approach , 2001 .
[3] W.A.H. Thissen,et al. A modelling approach , 2010 .
[4] P. Sawicki,et al. Screening for diabetes: hope and despair , 2012, Diabetologia.
[5] M Elisabeth Paté-Cornell,et al. Early technology assessment of new medical devices , 2008, International Journal of Technology Assessment in Health Care.
[6] Risto Lahdelma,et al. SMAA - Stochastic multiobjective acceptability analysis , 1998, Eur. J. Oper. Res..
[7] A. D. Henriksen,et al. A practical R&D project-selection scoring tool , 1999 .
[8] Tommi Tervonen,et al. Hit-And-Run enables efficient weight generation for simulation-based multiple criteria decision analysis , 2013, Eur. J. Oper. Res..
[9] Gimon de Graaf,et al. A method for the early health technology assessment of novel biomarker measurement in primary prevention programs , 2012, Statistics in medicine.
[10] H. Bilo,et al. Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines. , 2000, Health policy.
[11] Henry Petroski,et al. Crossing the Valley of Death , 2017 .
[12] Richard J. Lilford,et al. Investing in new medical technologies: A decision framework , 2007 .
[13] M A Koopmanschap,et al. Resource consumption and costs in Dutch patients with Type 2 diabetes mellitus. Results from 29 general practices , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[14] Douwe Postmus,et al. Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] P. Engelfriet,et al. Opportunities for preventing diabetes and its cardiovascular complications , 2008 .
[16] M. Fowler. Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.
[17] Diederick E. Grobbee,et al. The global burden of diabetes and its complications: an emerging pandemic , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[18] G. Nijpels,et al. Finse vragenlijst redelijk goede voorspeller van het optreden van diabetes in Nederland , 2008 .
[19] D. Butler. Translational research: Crossing the valley of death , 2008, Nature.
[20] Jill U. Adams. Building the bridge from bench to bedside , 2008, Nature Reviews Drug Discovery.
[21] Pin-Yu Chu,et al. A fuzzy AHP application in government-sponsored R&D project selection☆ , 2008 .
[22] Risto Lahdelma,et al. SMAA-2: Stochastic Multicriteria Acceptability Analysis for Group Decision Making , 2001, Oper. Res..
[23] Kaisa Miettinen,et al. Ordinal criteria in stochastic multicriteria acceptability analysis (SMAA) , 2003, Eur. J. Oper. Res..
[24] Maarten J. IJzerman,et al. Early assessment of medical technologies to inform product development and market access , 2011, Applied health economics and health policy.